4-((1H-1,2,4-triazol-3-yl)thio)-7-(benzyloxy)-6-methoxyquinazoline

ID: ALA4877965

PubChem CID: 164628734

Max Phase: Preclinical

Molecular Formula: C18H15N5O2S

Molecular Weight: 365.42

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(Sc3nc[nH]n3)ncnc2cc1OCc1ccccc1

Standard InChI:  InChI=1S/C18H15N5O2S/c1-24-15-7-13-14(8-16(15)25-9-12-5-3-2-4-6-12)19-10-20-17(13)26-18-21-11-22-23-18/h2-8,10-11H,9H2,1H3,(H,21,22,23)

Standard InChI Key:  VGXQILSJTYIDKJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    3.6842  -18.6261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6831  -19.4457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3911  -19.8546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3893  -18.2173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0979  -18.6225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0987  -19.4416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8072  -19.8486    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5155  -19.4378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5108  -18.6157    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8016  -18.2123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9764  -18.2177    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2688  -18.6265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9750  -19.8537    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2676  -19.4446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7973  -17.3951    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.5028  -16.9828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2501  -17.3067    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7937  -16.6965    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3813  -15.9909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5829  -16.1652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5596  -19.8526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8509  -19.4448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1434  -19.8522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1423  -20.6702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8546  -21.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5593  -20.6695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  1 11  1  0
 11 12  1  0
  2 13  1  0
 13 14  1  0
 10 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  2  0
 20 16  1  0
 19 18  1  0
 14 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4877965

    ---

Associated Targets(Human)

KDM1A Tchem Lysine-specific histone demethylase 1 (3916 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 365.42Molecular Weight (Monoisotopic): 365.0946AlogP: 3.49#Rotatable Bonds: 6
Polar Surface Area: 85.81Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.67CX Basic pKa: 1.59CX LogP: 3.91CX LogD: 3.91
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.52Np Likeness Score: -1.08

References

1. Li Z, Qin T, Li Z, Zhao X, Zhang X, Zhao T, Yang N, Miao J, Ma J, Zhang Z..  (2021)  Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing.,  225  [PMID:34416665] [10.1016/j.ejmech.2021.113778]

Source